JP2018529674A5 - - Google Patents

Download PDF

Info

Publication number
JP2018529674A5
JP2018529674A5 JP2018511682A JP2018511682A JP2018529674A5 JP 2018529674 A5 JP2018529674 A5 JP 2018529674A5 JP 2018511682 A JP2018511682 A JP 2018511682A JP 2018511682 A JP2018511682 A JP 2018511682A JP 2018529674 A5 JP2018529674 A5 JP 2018529674A5
Authority
JP
Japan
Prior art keywords
solid particulate
particulate formulation
pyrophosphate
weight
item
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018511682A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018529674A (ja
JP7055738B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/050120 external-priority patent/WO2017040937A1/en
Publication of JP2018529674A publication Critical patent/JP2018529674A/ja
Publication of JP2018529674A5 publication Critical patent/JP2018529674A5/ja
Application granted granted Critical
Publication of JP7055738B2 publication Critical patent/JP7055738B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018511682A 2015-09-04 2016-09-02 固体の可溶性ピロリン酸第二鉄製剤、キット、およびそれを使用する方法 Expired - Fee Related JP7055738B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562214908P 2015-09-04 2015-09-04
US62/214,908 2015-09-04
PCT/US2016/050120 WO2017040937A1 (en) 2015-09-04 2016-09-02 Solid soluble ferric pyrophosphate formulations, kits, and methods using the same

Publications (3)

Publication Number Publication Date
JP2018529674A JP2018529674A (ja) 2018-10-11
JP2018529674A5 true JP2018529674A5 (cg-RX-API-DMAC7.html) 2019-10-17
JP7055738B2 JP7055738B2 (ja) 2022-04-18

Family

ID=56926337

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018511682A Expired - Fee Related JP7055738B2 (ja) 2015-09-04 2016-09-02 固体の可溶性ピロリン酸第二鉄製剤、キット、およびそれを使用する方法

Country Status (18)

Country Link
US (1) US11517555B2 (cg-RX-API-DMAC7.html)
EP (1) EP3344235A1 (cg-RX-API-DMAC7.html)
JP (1) JP7055738B2 (cg-RX-API-DMAC7.html)
KR (1) KR20180050346A (cg-RX-API-DMAC7.html)
CN (1) CN108601738A (cg-RX-API-DMAC7.html)
AU (1) AU2016315877B2 (cg-RX-API-DMAC7.html)
BR (1) BR112018004244A2 (cg-RX-API-DMAC7.html)
CA (1) CA2997328A1 (cg-RX-API-DMAC7.html)
CL (1) CL2018000566A1 (cg-RX-API-DMAC7.html)
CO (1) CO2018002421A2 (cg-RX-API-DMAC7.html)
EA (1) EA201890642A1 (cg-RX-API-DMAC7.html)
IL (1) IL257796B (cg-RX-API-DMAC7.html)
MX (1) MX2018002633A (cg-RX-API-DMAC7.html)
PE (1) PE20181162A1 (cg-RX-API-DMAC7.html)
PH (1) PH12018500463A1 (cg-RX-API-DMAC7.html)
SG (1) SG10202107245UA (cg-RX-API-DMAC7.html)
UA (1) UA124923C2 (cg-RX-API-DMAC7.html)
WO (1) WO2017040937A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11278651B2 (en) * 2018-10-17 2022-03-22 Gambro Lundia Ab Membrane and device for treating restless leg syndrome
CN110063965A (zh) * 2019-06-04 2019-07-30 吉林省富生医疗器械有限公司 一种血液透析浓缩物
FR3109734B1 (fr) * 2020-05-04 2025-04-11 Univ Claude Bernard Lyon Système de dialyse pour le traitement du sepsis

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5177068A (en) * 1984-04-19 1993-01-05 National Research Development Corporation Pharmaceutical compositions
WO1997014407A1 (en) * 1995-10-17 1997-04-24 Research Triangle Pharmaceuticals Insoluble drug delivery
US6779468B1 (en) 1997-08-07 2004-08-24 Ajay Gupta Method and pharmaceutical composition for iron delivery in hemodialysis and peritoneal dialysis patients
US6689275B1 (en) 1996-12-31 2004-02-10 Ajay Gupta Method and pharmaceutical composition for replacing iron losses in dialysis patients
JP3778240B2 (ja) 1998-06-22 2006-05-24 ライオン株式会社 不快な味がマスキングされた造粒組成物及びその製造方法
CA2344548C (en) * 1998-09-18 2007-03-13 Rockwell Medical Technologies, Inc. Method and apparatus for preparing liquid dialysate
WO2001080828A2 (en) * 2000-04-20 2001-11-01 Rtp Pharma Inc. Improved water-insoluble drug particle process
CA2433169A1 (en) 2000-12-26 2002-07-04 Takeda Chemical Industries, Ltd. Porous substances and methods for producing the same
JP2002302435A (ja) * 2000-12-26 2002-10-18 Takeda Chem Ind Ltd 多孔性物質およびその製造法
US7754243B2 (en) * 2004-08-03 2010-07-13 Clemson University Research Foundation Aqueous suspension of nanoscale drug particles from supercritical fluid processing
US20060134227A1 (en) * 2004-12-22 2006-06-22 Bortz Jonathan D Compositions including iron
US7857977B2 (en) * 2005-07-12 2010-12-28 Rockwell Medical Technologies, Inc. Packaging of ferric pyrophosphate for dialysis
EP1743530B1 (en) * 2005-07-15 2011-08-31 Unilever N.V. Iron fortified food product and additive
US7816404B2 (en) * 2007-07-20 2010-10-19 Rockwell Medical Technologies, Inc. Methods for the preparation and use of ferric pyrophosphate citrate chelate compositions
US8178709B2 (en) 2009-07-21 2012-05-15 Biolink Life Sciences, Inc. Iron preparation suitable for pharmaceutical formulation and process for the preparation thereof
WO2012092305A2 (en) 2010-12-27 2012-07-05 Incube Labs, Llc Nanonized iron compositions and methods of use thereof
WO2014121155A1 (en) 2013-02-01 2014-08-07 Charak Llc Methods of treating iron deficiency with soluble ferric pyrophosphate

Similar Documents

Publication Publication Date Title
TWI583378B (zh) 透析酸前驅物組成物、其用途、以及提供透析酸濃縮物溶液之方法
JP2019194212A5 (cg-RX-API-DMAC7.html)
JP5752791B2 (ja) 透析酸前駆組成物
CN103796634B (zh) 透析前体组合物
CA2422850A1 (en) High citrate dialysate and uses thereof
JP2015527402A5 (cg-RX-API-DMAC7.html)
JP2019504086A5 (cg-RX-API-DMAC7.html)
CN103747789B (zh) 透析前体组合物
JP2018529674A5 (cg-RX-API-DMAC7.html)
JP2012066088A5 (cg-RX-API-DMAC7.html)
JP6366214B6 (ja) 血液透析用a剤
MY178888A (en) Dialysis a agent comprising acetic acid and acetate, and two-part dialysis agent using same
Elias et al. L-arginine as an adjuvant drug in the treatment of sickle cell anaemia.
EP2934483B1 (en) Dialysis composition
Li et al. Delivery of melarsoprol using folate-targeted PEGylated cyclodextrin-based nanoparticles for hepatocellular carcinoma
WO2010112547A1 (en) Dialysis precursor composition
JP7055738B2 (ja) 固体の可溶性ピロリン酸第二鉄製剤、キット、およびそれを使用する方法
CN104010645B (zh) 透析前体组合物
CN103120640B (zh) 一种栓塞剂及其制备方法
JP2008007523A (ja) 固形重曹透析用剤
JP6593047B2 (ja) 透析液用固形製剤
JP5282923B2 (ja) 重炭酸透析剤
NZ792574A (en) Sodium 2-[(4s)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4h-quinazolin-4-yl]acetate and pharmaceutical compositions thereof
JP6593048B2 (ja) 透析液用固形製剤およびその製造方法
ES2984013T3 (es) Composiciones de hidróxido de hierro férrico modificado con ligando carboxilato para su uso en el tratamiento o prevención de la deficiencia de hierro asociada con enfermedades hepáticas